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Stability and Optimal Control of a Delayed
HIV Model
Diana Rochaa, Cristiana J. Silvaa and Delfim F. M. Torresa∗
We propose and investigate a delayed model that studies the relationship between HIV and the immune system during
the natural course of infection and in the context of antiviral treatment regimes. Sufficient criteria for local asymptotic
stability of the infected and viral free equilibria are given. An optimal control problem with time delays both in state
variables (incubation delay) and control (pharmacological delay) is then formulated and analyzed, where the objective
consists to find the optimal treatment strategy that maximizes the number of uninfected CD4+ T cells as well as CTL
immune response cells, keeping the drug therapy as low as possible.
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1. Introduction
The study of mathematical models for human immunodeficiency virus (HIV) infection is a subject of strong current interest,
both at population and cell levels (see, e.g., [12, 17, 18] and references cited therein). Based on the model of [5], in this work
we analyze a mathematical model that studies the relationship between HIV and the immune system during the natural course
of infection and in the context of antiviral treatment regimes. The model considers three variables: uninfected CD4+ T cells,
denoted by x ; infected CD4+ T cells, denoted by y ; and CTL effectors (immune response cells), denoted by z . According to
[1], the viral load is assumed to be proportional to the level of infected cells. Uninfected CD4+ T cells are produced at a rate
λ, die at a rate d , and become infected at a rate β. Infected cells decay at a rate a and are killed by CTL effectors at a rate p.
Proliferation of the CTL population is given by cxyz and is proportional to both virus load (y) and the number of uninfected
CD4+ T cells (x). CTL effectors die at a rate h. Mathematically, the model [5] is described by


x˙ = λ− dx − βxy,
y˙ = βxy − ay − pyz,
z˙ = cxyz − hz.
(1)
Time delays play an important role in the dynamics of HIV infection: see, e.g., [13, 14] and references therein. For this reason,
in this work we introduce a discrete time-delay into the model (1), which represents the incubation period, that is, the time
between the new infection of a CD4+ T cell and the time it becomes infectious (Section 2). We prove local asymptotic stability
of the viral free and infected equilibriums, for any time delay (Section 3).
Optimal control theory has been applied with success to epidemiology HIV models: see, e.g., [5, 8] and references therein.
However, epidemiology optimal control problems with delays in both state and control variables are a rarity. For one such optimal
control problem, of a tuberculosis model, we refer the reader to the recent work of Silva, Maurer and Torres [16]. Here, we
propose and solve a HIV optimal control problem, with delays in both state and control variables, where the objective is to find
the optimal treatment strategy that maximizes the number of CD4+ T cells, as well as CTL immune response cells, keeping
the drug/chemotherapy strength, which depends on a pharmacological delay, as low as possible (Section 4). The stability and
optimal control results of Sections 3 and 4 are then illustrated through numerical simulations in Section 5. We end with Section 6
of conclusions and future work.
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2. Model with time delay τ
In epidemiological literature, a latent or incubation period is often modeled by incorporating it as a delay effect [10]. We consider
the following delayed model, where τ > 0 represents the incubation period:

x˙(t) = λ− dx(t)− βx(t)y(t),
y˙(t) = βx(t − τ)y(t − τ)− ay(t)− py(t)z(t),
z˙(t) = cx(t)y(t)z(t)− hz(t).
(2)
The initial conditions for system (2) are
x(θ) = ϕ1(θ), y(θ) = ϕ2(θ), z(θ) = ϕ3(θ), (3)
−τ ≤ θ ≤ 0, where ϕ = (ϕ1, ϕ2, ϕ3)T ∈ C with C the Banach space C
(
[−τ, 0],R3) of continuous functions mapping the interval
[−τ,0] into R3. The usual local existence, uniqueness and continuation results apply [7, 11]. Therefore, there exists a unique
solution (x(t), y(t), z(t)) of (2) with initial conditions (3), for all time t ≥ 0. From biological meaning, we further assume the
initial functions to be non-negative, that is,
ϕ(θ) ≥ 0 for θ ∈ [−τ,0], i = 1, . . . , 3. (4)
From [19, Theorem 2.1], it follows that all solutions of (2) satisfying (3) with (4) are bounded for all time t ≥ 0, which ensures
not only local existence but also the existence of a solution for all time t ≥ 0.
It is easy to see that system (2) has an infection-free equilibrium
E0 =
(
λ
d
, 0, 0
)
, (5)
which is the only biologically meaningful equilibrium if β < daλ . Let β >
da
λ and assume that λc − βh > 0. If β < acdλc−βh , then
system (2) has a unique infected equilibrium E1 given by
E1 =
(
a
β
,
λβ − da
βa
, 0
)
. (6)
Assume that λc − βh > 0. Whenever β > acdλc−βh , the unique infected equilibrium of system (2) is given by the CTL equilibrium
E2 =
(
λc − βh
cd
,
dh
λc − βh ,
β(λc − βh)
cdp
− a
p
)
. (7)
3. Local asymptotic stability
Consider the following coordinate transformation:
X(t) = x(t)− x¯ , Y (t) = y(t)− y¯ , Z(t) = z(t)− z¯ ,
where (x¯ , y¯ , z¯) denotes any equilibrium of (2): E0, E1 or E2. The linearized system of (2) is of form

X˙(t) = (−d − βy¯)X(t)− βx¯Y (t) ,
Y˙ (t) = (−a − pz¯)Y (t) + βy¯X(t − τ) + βx¯Y (t − τ)− py¯Z(t) ,
Z˙(t) = cy¯ z¯X(t) + cx¯ z¯Y (t) + (cx¯ y¯ − h)Z(t) .
(8)
We can express system (8) in matrix notation as follows:
d
dt

 X(t)Y (t)
Z(t)

 = A1

 X(t)Y (t)
Z(t)

+ A2

 X(t − τ)Y (t − τ)
Z(t − τ)

 ,
where A1 and A2 are the 3× 3 matrices given by
A1 =

 −d − βy¯ −βx¯ 00 −a − pz¯ −py¯
cy¯ z¯ c x¯ z¯ c x¯ y¯ − h


and
A2 =

 0 0 0βy¯ βx¯ 0
0 0 0

 .
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3.1. Local stability of the infection-free equilibrium E0 for any time delay τ
The characteristic equation of system (2) is given by
∆(λ1) = det(λ1Id − A1 − e−λ1τA2) = 0, (9)
where Id denotes the identity matrix of dimension 3. The following result holds.
Theorem 1 (i) If βλ− ad < 0, then the infection-free equilibrium E0 (5) is locally asymptotically stable for any time delay
τ ≥ 0. (ii) If βλ− ad > 0, then E0 (5) is unstable for any time-delay τ ≥ 0. (iii) If βλ− ad = 0, then a critical case occurs.
Proof: (i) The characteristic equation (9) associated to the infection-free equilibrium is given by
(d + λ1)(h + λ1)(ad + dλ1 − βλe−λ1τ )
d
= 0 . (10)
Assume that τ = 0. In this case, the equation (10) becomes
(d + λ1)(h + λ1)(ad + dλ1 − βλe−λ1τ )
d
= 0 . (11)
The roots of (11) are −d , −h and βλ−dad , which have negative real part when βλ− da < 0. Suppose that τ > 0. To prove
the stability of E0 we use Rouche´’s theorem. Thus, we need to prove that the roots of the characteristic equation (10) cannot
intersect the imaginary axis, i.e., the characteristic equation cannot have pure imaginary roots. Suppose the contrary, i.e., that
there exists a nonzero w such that b = wi is a solution of (10). Equation (10) has two real negative solutions −d and −h.
Therefore, in what follows we just consider the term ad+dλ1−βλe
−λ1τ
d
. The complex b = wi is a root of (10) if ad+dwi−βλe
−wiτ
d
= 0.
By using Euler’s formula exp−iwτ = cos(wτ)− i sin(wτ), and by separating real and imaginary parts, we have{
da = βλ cos(wτ)
dw = −βλ sin(wτ) .
Adding up the squares of both equations, we obtain that
d2w 2 + d2a2 − λ2β2 = 0,
that is,
w 2 =
λ2β2 − d2a2
d2
.
If βλ− da < 0, then w 2 < 0, which is a contradiction. We just proved that the characteristic equation (10) cannot have pure
imaginary roots and the infection-free equilibrium E0 is locally asymptotically stable for any strictly positive time delay.
(ii) Suppose now that βλ− da > 0. We know that the characteristic equation (10) has two real negative roots: λ1 = −d
and λ1 = −h. Thus, we must check if the remaining roots of function f (λ1) := a + λ1 − βλe−λ1τd have negative real parts. It is
easy to see that f (0) = a − βλd < 0, since we are assuming βλ− da > 0. On the other hand, limλ1→+∞ f (λ1) = +∞. Therefore,
by continuity of f (λ1), there is at least one positive root of the characteristic equation (10). Hence, we conclude that E0 is
unstable.
(iii) Finally, we analyze the case βλ− da = 0. In this situation, the characteristic equation (10) becomes
(d + λ1)(h + λ1)(λ1 + a − exp−λ1 τ a) = 0 . (12)
To prove the stability we need to check again if all the roots of the above equation have negative real parts. Notice that λ1 = 0,
λ1 = −d and λ1 = −h are solutions of this equation, so we just need to prove that the remaining roots cannot have nonnegative
real parts. Assuming that λ1 = u + wi with u ≥ 0 is a solution of the above equation, then
u + wi + a − exp−(u+wi)τ a = 0 .
By using Euler formula and separating the real and imaginary parts, we get{
u + a = e−uτa cos (wτ)
w = −e−uτa sin (wτ) .
By adding up the squares of both equations, and using the fundamental trigonometric formula, we obtain
(u + a)2 + w 2 = exp(−2uτ)a2 ≤ a2,
which is a contradiction. This proves that 0 is the unique root of (12) that does not have negative real part. 
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3.2. Local stability of the infected equilibrium E1 for any time delay τ
We now study the local stability of the the infected equilibrium E1 (6) for any incubation period τ .
Theorem 2 Let βλ− da > 0 and assume that λc − βh > 0. (i) If β(λc − βh)− acd < 0, then the infected equilibrium E1 is
locally asymptotically stable for any time delay τ ≥ 0. (ii) If β(λc − βh)− acd > 0, then E1 is unstable for any time delay τ ≥ 0.
Proof: Let βλ− da > 0 and λc − βh > 0. The characteristic equation (9) at E1 =
(
a
β ,
λβ−da
βa , 0
)
is given by
(
λ1 β
2 − β λ c + β2h + acd) (−λ21a − λ1 a2 + λ1 a2e−λ1 τ − λβ λ1 − λβ a + e−λ1 τa2d)
aβ2
= 0 . (13)
Note that λ1 =
β λ c−β2h−acd
β2
is a solution of (13). (i) If β(λc − βh)− acd < 0, then λ1 = β λ c−β2h−acdβ2 is a real negative root
of the characteristic equation (13) and we just need to analyze the equation
λ21a + λ1(a
2 + λβ) + λβ a − (λ1 + d)a2e−λ1 τ
aβ2
= 0 . (14)
Consider τ = 0. From equation (14), we have
λ1
2a + λβ λ1 + λβ a − a2d
aβ2
= 0. (15)
Since βλ− da > 0, it follows that 1
β2
> 0, λaβ > 0 and
λβ a−a2d
aβ2
= λβ−ad
β2
> 0. Therefore, from the Routh–Hurwitz criterion, it
follows that all roots of (15) have negative real part. Hence, E1 is locally asymptotically stable for τ = 0. Let τ > 0. Suppose
that (14) has pure imaginary roots ±wi . By replacing λ1 in (14) by wi , and separate the real and imaginary parts, we obtain{
−w 2a + λβ a = a2d cos (wτ) + wa2 sin (wτ)
wa2 + λβ w = wa2 cos (wτ)− a2d sin (wτ) .
By adding up the squares of both equations, and using the fundamental trigonometric formula, we obtain that
a2w 4 + w 2λ2β2 = a2(a2d2 − λ2β2) ,
which is a contradiction since βλ− da > 0. Therefore, a2d2 − λ2β2 < 0 and equation (14) does not have pure imaginary roots.
This implies that E1 is locally asymptotically stable for any time delay τ > 0. (ii) If β >
acd
λc−βh , then the characteristic equation
(13) has a positive root and consequently the equilibrium E1 is unstable for any time delay τ ≥ 0. 
3.3. Local stability of the CTL equilibrium E2
The analysis of the local stability of the CTL equilibrium E2 is more complex. Under some assumptions, the situation is clear
for τ = 0: the infected equilibrium E2 is locally asymptotically stable (see Theorem 3). However, for τ > 0, the characteristic
polynomial has pure imaginary roots and we are not able to conclude anything about the stability for an arbitrary τ > 0 (see
Remark 4). It is, however, possible to prove stability in some concrete situations of biological significance (see Remark 5).
Theorem 3 Assume that λc − βh > 0. If β(λc − βh)− acd > 0, then the infected equilibrium E2 is locally asymptotically stable
for τ = 0.
Proof: Let β(λc − βh)− acd > 0. The characteristic equation (9) at E2 (7) is given by
λ31 + Aλ
2
1 + Bλ1 + C +
(
−λ1 β (λ1(cλ− β h) + d(cλ− β h))
cd
)
exp(−λ1τ) = 0 , (16)
where
A =
λ2c2β + d2λ c2 − 2λ cβ2h + β3h2
(λc − β h) cd , B =
cλ dβ + cλβ h − chad − β2h2
cd
and C = −
(−β λ c + β2h + acd)h
c
.
If τ = 0, then the characteristic equation (16) is λ31 +Dλ
2
1 + Eλ1 + F = 0 with D =
dλ c
λ c−β h > 0, E =
(β λ c−acd+dβ2−β2h)h
cd > 0,
F =
(β λ c−β2h−acd)h
c > 0 and DE − F =
hβ (cλ dβ+h(cλ β−cad−β2h))
(λ c−β h)c > 0, whenever β(λc − βh)− acd > 0. 
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Remark 4 Let τ > 0. Suppose that (16) has pure imaginary roots ±wi . Replacing λ1 in (16) by wi , and separating the real
and imaginary parts, we obtain that 

Gw 2 + H = Jw 2 +Kw
Lw 3 +Mw = Nw 2 + Pw,
where
G = −β3h2 − β c2λ2 − c2d2λ + 2β2chλ ,
H = dλ2c2hβ + h2β d2ac − d2λ c2ha − 2 dλ cβ2h2 + h3β3d ,
J = β
(
β2h2 cos (wτ) + λ2c2 cos (wτ)− 2λ cβ h cos (wτ)) ,
K = β
(−dλ2c2 sin (wτ) + 2 dλ cβ h sin (wτ)− β2h2d sin (wτ)) ,
L = −λc2d + β hcd ,
M = β3h3 − λ c2had − dλ cβ2h + β h2acd − 2λ cβ2h2 + dλ2c2β + λ2c2hβ ,
N = −β (sin (wτ) c2λ2 − 2 sin (wτ)β chλ+ sin (wτ)β2h2) ,
P = −β (cos (wτ)β2dh2 − 2 cos (wτ)β cdhλ+ cos (wτ) c2dλ2) .
By adding up the squares of both equations, and using the fundamental trigonometric formula, we obtain that
Qw 6 + Rw 4 + Sw 2 + T = 0, (17)
where
Q = λ2c4d2 + β2h2c2d2 − 2λc3d2β h,
R = 6λ2c3dβ2h2 + 2λ2c4d2ha+ d4λ2c4 + 2β4h4cd − 2λ3c4dchβ + 2β2h3ac2d2 − 6β3h3λ c2d − 4λ c3d2β h2a,
S = −2β6h5d − β6d2h4 − 2 d3λ3c4hβ − 2 h3β3d3λc2 − 2β4h4d2ac + 2 d4λ2c4ha
+ 4 d3λ2c3β2h2 + 4β5h3d2λ c − 6β3h4λc2ad − 2λ2c3h2ad2β2 − 2λ c3h3a2d2β
+ 6λ2c3h3adβ2 − 2λ3c4h2adβ + 4 d2λ c2β3h3a + β6h6 − 4β5h5λ c + 6β4h4λ2c2
− 4λ3c3β3h3 + λ4c4h2β2 − 2 h2β d4ac3λ+ 6β5h4dλ c + 2β4h5acd − 6β4h3dλ2c2
+ λ2c4h2a2d2 − 5 d2λ2c2β4h2 + 2 d2λ3c3β3h + 2 dλ3c3β3h2 + β2h4a2c2d2,
T = −4 d2λ3c3β3h3 − 4 d2λ cβ5h5 + d2λ4c4h2β2 − 2 h3β d4a2c3λ− 6 h4β3d3ac2λ+ h6β6d2
+ h4β2d4a2c2 + 2 h5β4d3ac + 6 h3β2d3ac3λ2 − 2 d3λ3c4h2aβ + d4λ2c4h2a2 + 6 d2λ2c2β4h4 .
This equation admits at least two pure imaginary roots. Indeed, let λ = 1, d = 110 , β =
1
2 , a =
1
5 , p = 1, c =
1
10 and h =
1
10 .
Then, λc − βh = 120 > 0, β(λc − βh)− acd = 231000 > 0 and equation (17) is given by
w 6 − 21
50
w 4 +
1731
5000
w 2 +
529
1000000
= 0 .
This equation admits two pure imaginary roots given by
1/20 i
√
2
√
3
√
174036 + 4
√
5409904729
((
174036 + 4
√
5409904729
)2/3 − 3832− 28 3√174036 + 4√5409904729)
3
√
174036 + 4
√
5409904729
and
−1/20 i√2
√
3
√
174036 + 4
√
5409904729
((
174036 + 4
√
5409904729
)2/3 − 3832 − 28 3√174036 + 4√5409904729)
3
√
174036 + 4
√
5409904729
.
Therefore, from Rouche´ theorem, we cannot conclude anything about the stability of the CTL equilibrium E2.
Remark 5 According with different studies, the eclipse phase represented by the time delay τ can take from 7 to 21 days
[2, 3, 4, 9]. Based on this, let us assume τ = 10 days. In Section 5 we show, numerically, that the infected equilibrium E2 is
locally asymptotically stable for τ = 10 and the parameter values from Table 1 with β = 0.5. This is easy to show analytically:
the characteristic equation (16) in this case is given by q(λ1) = 0 with
q(λ1) = −1/4 e−λ1 τλ1 − 5
2
e−λ1 τλ1
2 +
23
1000
+
73λ1
100
+
27λ1
2
10
+ λ1
3,
q(0) = 23/1000, and the derivative is always positive for λ1 ≥ 0. Therefore, q(λ1) does not have nonnegative real roots.
Analogously, we can show that E2 is locally asymptotically stable for other positive values of the time delay τ . This will be
considered in Section 5.
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4. Optimal control problem with state and control delays
It is interesting to introduce drug therapy into the model by assuming that treatment reduces the rate of viral replication,
expressed by (1− u)βxy , where 0 ≤ u ≤ 1. Our aim is to find a treatment strategy u(t) that maximizes the number of CD4+
T cells x as well as the number of CTL immune response cells z , keeping the cost, measured in terms of chemotherapy strength
and a combination of duration and intensity, as low as possible. Due to the importance of the pharmacological delay in the HIV
treatment, we consider a discrete time delay in the control variable u(t), denoted by ξ, which represents the delay that occurs
between the administration of drug and its appearance within cells, due to the time required for drug absorption, distribution,
and penetration into the target cells [15]. Precisely, we propose the following control system with discrete time delays in state
and control variables: 

x˙(t) = λ− dx(t)− (1− u(t − ξ))βx(t)y(t),
y˙(t) = (1− u(t − ξ))βx(t − τ)y(t − τ)− ay(t)− py(t)z(t),
z˙(t) = cx(t)y(t)z(t)− hz(t).
(18)
The initial conditions for the state variable z and, due to the delays, initial functions for the state variables x and y and control
u, are given by
z(0) = z0 ≥ 0,
x(t) ≡ x0 ≥ 0 for − τ ≤ t ≤ 0,
y(t) ≡ y0 ≥ 0 for − τ ≤ t ≤ 0,
u(t) ≡ u0, where u0 ∈ [0, 1], for − ξ ≤ t < 0.
(19)
The set of admissible control functions is given by
Θ =
{
u(·) ∈ L1 ([0, tf ],R) | 0 ≤ u(t) ≤ 1 ∀ t ∈ [0, tf ]
}
and the objective functional is
J(u(·)) =
∫ tf
0
[x(t) + z(t)− u(t)] dt, (20)
which measures the concentration of CD4+ T and CTL cells and the cost measured in terms of chemotherapy strength and
a combination of duration and intensity. The optimal control problem consists in determining a control function u(·) ∈ Θ that
maximizes the cost functional (20) subject to the control system (18) and initial conditions (19). In [5], the authors consider a
different L2 cost functional for a non-delayed control system. We claim that our delayed control system (18) describes better
the reality. Moreover, as we shall see, the extremals obtained with our L1 cost functional (20) are easier to implement from a
medical point of view.
We apply the optimality conditions given by the Pontryagin Maximum Principle for multiple delayed optimal control problems of
Go¨llmann and Maurer [6, Theorem 3.1]. For that, we introduce the delayed state variables ζ(t) = x(t − τ), η(t) = y(t − τ) and
the control variable v(t) = u(t − ξ). Using the adjoint variable ψ = (λx , λy , λz) ∈ R3, the Hamiltonian for the cost functional
(20) and the control system (18) is given by
H(x, ζ, y , η, z, ψ, u, v) = x + z − u + λx (λ − dx − (1− v)βxy) + λy ((1− v)βζη − ay − pyz) + λz (cxyz − hz) .
The adjoint equations are given by 

λ˙x (t) = −Hx [t]− χ[0,tf −τ ]Hζ[t + τ ],
λ˙y (t) = −Hy [t]− χ[0,tf −τ ]Hη[t + τ ],
λ˙z(t) = −Hz [t],
where the subscripts denote partial derivatives and χ[0,tf −τ ] is the characteristic function on the interval [0, tf − τ ] (see [6]).
Since the terminal state is free, i.e., (x(tf ), y(tf ), z(tf )) ∈ R3, the transversality conditions
λx(tf ) = λy (tf ) = λz(tf ) = 0
hold. To characterize the optimal control u, we introduce the following switching function:
φ(t) = Hu[t] + χ[0,tf −ξ]Hv [t + ξ]
=
{
−1 + λx(t + ξ)βx(t + ξ)y(t + ξ)− λyβζ(t + ξ)η(t + ξ) for 0 ≤ t ≤ tf − ξ,
−1 for tf − ξ ≤ t ≤ tf .
The maximality condition of the Pontryagin Maximum Principle [6, Theorem 3.1] gives the control law
u(t) =


1 if φ(t) > 0,
0 if φ(t) < 0,
singular if φk(t) = 0 on Is ⊂ [0, tf ].
(21)
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5. Numerical simulations
We begin by showing numerically, in Section 5.1, the local stability of the equilibrium points E0 and E2 that was proved in
Section 3. Then, in Section 5.2, we apply the necessary conditions of optimal control of Section 4 to a situation of fast
convergence to the CTL equilibrium E2.
5.1. Stability of the equilibrium points
Following [5, 18], we consider the parameter values of Table 1.
Parameter Description Value
λ source rate of CD4 + T cells 1 cel ls/day
d decay rate of CD4 + T cells 0.1 cel ls/day
β rate CD4 + T cells become infected [0.00025, 0.5] cel ls/day
a death rate infected, not by CTL killing 0.2 cel ls/day
p rate at which infected cells are killed by CTLs 1/day
c immune response activation rate 0.1/day
h death rate of CTLs 0.1/day
Table 1. Parameter values.
Two different initial conditions for the state variable z and, due to the delays, initial functions for the state variables x and y ,
are considered:
x(t) ≡ 45, y(t) ≡ 3, −τ ≤ t ≤ 0,
z(0) = 20,
(22)
and
x(t) ≡ 5, y(t) ≡ 1, −τ ≤ t ≤ 0,
z(0) = 2.
(23)
Consider the parameter values of Table 1 and β = 0.00025. For these parameter values, we have βλ− da = −0.0208 < 0. Let
the time delay τ be equal to 10 days: τ = 10. In Figure 1 we observe the convergence of the variables x , y , z to the steady
state E0 =
(
λ
d , 0, 0
)
= (10, 0, 0).
0 100 200 300 400 500
5
10
15
20
25
30
35
40
45
time (days)
x
τ = 10
(a) x(t), t ∈ [0, 500]
−0.5 0 0.5 1 1.5 2 2.5 3
−5
0
5
10
15
20
25
30
35
y
z
τ = 10
(b) (y(t), z(t), t ∈ [0, 500]
Figure 1. Infection-free equilibrium E0 for parameter values given in Table 1, β = 0.00025 and time delay τ = 10 days. The dashed line corresponds to the
initial conditions (22) and the continuous line corresponds to the initial conditions (23).
The initial conditions (23) are closer to the infected equilibrium point E2 for the parameter values of Table 1 and β = 0.5. For
these parameter values, one has βλ− da = 0.48 > 0, λc − βh = 0.05 > 0 and β(λc − βh)− acd = 0.023 > 0. In Figure 2,
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we observe the convergence of the variables x , y , z to the steady state E2 =
(
λc−βh
cd ,
dh
λc−βh ,
β(λc−βh)
cdp − ap
)
= (5, 0.2, 2.3) by
considering the initial conditions (22) and (23) and τ = 10.
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Figure 2. Endemic CTL equilibrium E2 for the parameter values given in Table 1, β = 0.5 and time delay τ = 10. The dashed line corresponds to the initial
conditions (22) and the continuous line corresponds to the initial conditions (23).
There are situations where the convergence to stability is much slower. This is illustrated in Figure 3: slower convergence for
τ = 10 versus faster convergence for τ = 1.
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Figure 3. Endemic CTL equilibrium E2 for parameter values given in Table 1, β = 0.5 and initial conditions (23). The dashed line corresponds to τ = 10 and
the continuous line corresponds τ = 1.
5.2. Optimal control
Let us consider the initial conditions (23) and the initial function for the control given by
u(0) ≡ 0, −ξ ≤ t < 0.
The extremal for the non-delayed (i.e., τ = ξ = 0) optimal control problem with a L2 functional was investigated in [5]. Figure 4
shows that the extremal control for the L1 functional (20) is completely different from the L2 case studied in [5]: with τ = ξ = 0
and the L1 functional (20), the extremal control is bang-bang with several switchings while the L2 control extremal [5] is singular
after an initial short period of time. We conclude that the L1 functional (20) is more suitable, from a medical point of view,
because a bang-bang control is much easier to implement than the singular control of [5]. Moreover, we note that in [5] the
extremal trajectory z(t) is zero at the final time and the objective is to maximize x(t) and z(t). Our extremal z(t) is always
positive and is therefore better than the one of [5]: compare our Figure 4 with Figure 4.1 on page 557 of [5].
Let us now consider an optimal control problem with both incubation and pharmacological time delays. For illustrative purposes,
let τ = 0.5 and ξ = 0.1. We see from Figure 5 that the extremal state variables are similar to the ones without delay shown
in Figure 4. Importantly, the number of switchings of the extremal control has decreased, which makes it even more simpler to
implement in practice.
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Figure 4. Extremal solutions of the optimal control problem for t ∈ [0, 10] and τ = ξ = 0.
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Figure 5. Extremal solutions of the optimal control problem for t ∈ [0, 10], τ = 0.5 and ξ = 0.1.
6. Conclusion
We have proposed a new model for the optimal control of HIV at cell level, which considers not only an intracellular delay (delay
τ in the state variables) but also a pharmacological delay (delay ξ in the control function). Local stability of the equilibria was
investigated and the extremal control derived from application of the Pontryagin necessary optimality condition of Go¨llmann and
Maurer [6, Theorem 3.1].
The extremal control for our optimal control problem, with the same values for the parameters as those of [5, 18], is bang-
bang, that is, it attains alternately the boundary values 0 and 1. This type of control is easier to implement, from a medical
point of view, and leads to better results than the ones previously obtained in [5] for a non-delayed problem with a L2 functional.
We offer to the community three open questions: (i) how to prove stability of the CTL equilibrium (7) for an arbitrary τ > 0
(see Remark 4); (ii) how to prove sufficient conditions of optimality for our problem with delays in both state and control
variables; (iii) how to solve our optimal control problem numerically when one increases tf , τ and ξ.
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